CVS Health has released its first-quarter financial highlights, showcasing significant growth in total revenues by 7.0% compared to the prior year, reaching $94.6 billion.
The company’s earnings per share (EPS) have also seen a substantial increase. GAAP diluted EPS stands at $1.41, while Adjusted EPS is $2.25. Moreover, CVS Health has generated $4.6 billion in cash flow from operations.
In terms of operational updates, CVS Health plans to exit the individual exchange business, introducing new solutions to ease patient and provider experiences through its Aetna brand. Additionally, CVS Caremark has made a formulary update to improve access to GLP-1 drugs.
The company has revised its full-year guidance for 2025, raising GAAP diluted EPS expectations to $4.23-$4.43 per share and Adjusted EPS to $6.00-$6.20 per share. Furthermore, cash flow from operations is now projected at approximately $7.0 billion.
In a statement, CVS Health President and CEO David Joyner emphasized the company’s commitment to delivering high-quality care and services to its 185 million customers, driven by its focus on customer satisfaction and collaboration with colleagues across various business segments.
Source: https://www.cvshealth.com/news/company-news/cvs-health-corporation-reports-first-quarter-2025-results-and-updates-full-year-2025.html